Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.

MT: Non-coding RNAs gene addition gene silencing gene therapy lentiviral vectors microRNA sickle cell disease βs silencing

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
13 Jun 2023
Historique:
received: 30 07 2022
accepted: 17 03 2023
medline: 24 4 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: epublish

Résumé

Sickle cell disease (SCD) is due to a mutation in the β-globin gene causing production of the toxic sickle hemoglobin (HbS; α

Identifiants

pubmed: 37090420
doi: 10.1016/j.omtn.2023.03.012
pii: S2162-2531(23)00071-9
pmc: PMC10113710
doi:

Types de publication

Journal Article

Langues

eng

Pagination

229-246

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

M.B., F.M., M.C., M.A., and A.M. are the inventors of two patents describing bifunctional LVs for hemoglobinopathies.

Références

Blood. 1984 Apr;63(4):921-6
pubmed: 6200161
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
PLoS One. 2012;7(10):e47175
pubmed: 23071749
Blood. 2019 Oct 10;134(15):1203-1213
pubmed: 31467062
N Engl J Med. 2022 Feb 17;386(7):617-628
pubmed: 34898139
Lancet. 2017 Jul 15;390(10091):311-323
pubmed: 28159390
Hum Gene Ther. 2019 Jun;30(6):753-761
pubmed: 30700149
J RNAi Gene Silencing. 2011;7:434-42
pubmed: 21769296
Mol Ther Methods Clin Dev. 2020 Mar 17;17:589-600
pubmed: 32300607
Blood Adv. 2020 May 12;4(9):2058-2063
pubmed: 32396618
Blood. 2017 Sep 28;130(13):1597-1599
pubmed: 28830890
Blood. 2014 Jan 23;123(4):481-5
pubmed: 24222332
Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162
pubmed: 30423142
Biomaterials. 2017 Sep;139:102-115
pubmed: 28599149
Mol Ther. 2022 Jan 5;30(1):145-163
pubmed: 34418541
Ann Hematol. 2008 May;87(5):375-9
pubmed: 18026953
Blood Cells Mol Dis. 2018 May;70:54-65
pubmed: 28651846
Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5868-73
pubmed: 18398004
Silence. 2011 Oct 26;2:8
pubmed: 22029761
Mol Ther. 2015 Sep;23(9):1465-74
pubmed: 26080908
N Engl J Med. 2021 Jan 21;384(3):252-260
pubmed: 33283989
PLoS One. 2014 Mar 26;9(3):e92188
pubmed: 24670775
PLoS One. 2013;8(3):e59890
pubmed: 23533656
N Engl J Med. 2017 Apr 20;376(16):1561-1573
pubmed: 28423290
Nat Med. 2022 Jan;28(1):81-88
pubmed: 35075288
Sci Adv. 2020 Feb 12;6(7):
pubmed: 32917636
J R Soc Med. 2016 Aug;109(8):303-9
pubmed: 27325377
N Engl J Med. 2017 Mar 2;376(9):848-855
pubmed: 28249145
Mol Ther Methods Clin Dev. 2018 Aug 04;10:268-280
pubmed: 30140714
Nat Med. 2019 Feb;25(2):234-241
pubmed: 30664781
N Engl J Med. 2021 Jan 21;384(3):205-215
pubmed: 33283990
Cell. 2018 Apr 5;173(2):430-442.e17
pubmed: 29606353
Mol Ther. 2021 Sep 1;29(9):2841-2853
pubmed: 33940155
Blood. 2018 Apr 26;131(17):1960-1973
pubmed: 29519807
Nature. 2015 Nov 12;527(7577):192-7
pubmed: 26375006
Mol Ther. 2022 Aug 3;30(8):2693-2708
pubmed: 35526095
N Engl J Med. 2022 Feb 3;386(5):415-427
pubmed: 34891223
Haematologica. 2021 Oct 01;106(10):2740-2745
pubmed: 34047176
Haematologica. 2014 Nov;99(11):1677-85
pubmed: 25107887
Nature. 2010 Sep 16;467(7313):318-22
pubmed: 20844535
Nat Rev Drug Discov. 2019 Jun;18(6):447-462
pubmed: 30858502
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Blood. 2021 Mar 18;137(11):1553-1555
pubmed: 33512468
Mol Ther. 2009 Jan;17(1):169-75
pubmed: 19002161
J Biol Chem. 2015 Sep 25;290(39):23523-7
pubmed: 26296885
Blood. 2016 Aug 25;128(8):1139-43
pubmed: 27405777
Nat Biotechnol. 2022 Dec;40(12):1807-1813
pubmed: 35773341
J Clin Invest. 2016 Oct 3;126(10):3868-3878
pubmed: 27599293
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
N Engl J Med. 2022 Jan 13;386(2):138-147
pubmed: 34898140
Blood. 2011 Jul 7;118(1):19-27
pubmed: 21490337
Arch Intern Med. 1983 May;143(5):1030-2
pubmed: 6679216
Nat Biotechnol. 2006 Jan;24(1):89-94
pubmed: 16378095
CRISPR J. 2022 Feb;5(1):19-30
pubmed: 35099280
Int J Mol Sci. 2021 Mar 31;22(7):
pubmed: 33807258
Mol Ther. 2009 Jun;17(6):1039-52
pubmed: 19293777
Nucleic Acids Res. 2007;35(15):5154-64
pubmed: 17660190
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5953-8
pubmed: 16585504
Mol Ther Nucleic Acids. 2020 Mar 6;19:572-580
pubmed: 31927330
Mol Ther Methods Clin Dev. 2018 Mar 10;9:257-269
pubmed: 29707600
Gene Ther. 2022 Sep;29(9):536-543
pubmed: 35194185
Nucleic Acids Res. 1998 Feb 1;26(3):721-9
pubmed: 9443963

Auteurs

Mégane Brusson (M)

Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR1163, 75015 Paris, France.

Anne Chalumeau (A)

Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR1163, 75015 Paris, France.

Pierre Martinucci (P)

Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR1163, 75015 Paris, France.

Oriana Romano (O)

Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Department of Molecular Medicine, University of Padova, 35131 Padova, Italy.

Tristan Felix (T)

Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR1163, 75015 Paris, France.

Valentina Poletti (V)

Woman and Child Health Department, University of Padova, Padova, Italy.
Harvard Medical School, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Pediatric Research Institute, City of Hope, Padova, Italy.

Samantha Scaramuzza (S)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Sophie Ramadier (S)

Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR1163, 75015 Paris, France.

Cecile Masson (C)

Paris-Descartes Bioinformatics Platform, Imagine Institute, 75015 Paris, France.

Giuliana Ferrari (G)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute, San Raffaele University, Milan, Italy.

Fulvio Mavilio (F)

Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Department of Molecular Medicine, University of Padova, 35131 Padova, Italy.

Marina Cavazzana (M)

Université de Paris, 75015 Paris, France.
Imagine Institute, 75015 Paris, France.
Biotherapy Department and Clinical Investigation Center, Assistance Publique Hôpitaux de Paris, INSERM, 75015 Paris, France.

Mario Amendola (M)

Genethon, 91000 Evry, France.
Université Paris-Saclay, University Evry, INSERM, Genethon, Integrare Research Unit UMR_S951, 91000 Evry, France.

Annarita Miccio (A)

Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR1163, 75015 Paris, France.

Classifications MeSH